ctrl K

Price Alert

Anbio Biotechnology Class... (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

51.36

1.22 (2.43%)

At close: Aug 15, 2025, 12:32 PM

Anbio Biotechnology Class A Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022
Cash & Equivalents	11.76M	10.31M	9.69M	10.56M	7.1M
Short-Term Investments	n/a	n/a	n/a	n/a	1.57M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	387.44K	176.99K	62.14K	276.8K	2.99K
Receivables	1.06M	4.62M	1.88M	3.58K	3.58K
Inventory	n/a	n/a	n/a	n/a	353.87K
Other Current Assets	n/a	n/a	n/a	n/a	n/a
Total Current Assets	18.53M	18.77M	15.75M	15.15M	13.94M
Property-Plant & Equipment	n/a	n/a	n/a	3.27K	12.06K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	387.44K	176.99K	62.14K	280.07K	15.05K
Total Assets	18.92M	18.94M	15.81M	15.43M	13.96M
Account Payables	1.63M	478.96K	827.15K	1.31M	1.41M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	1.73M	527.75K	993.06K	1.34M	1.41M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Liabilities	1.73M	527.75K	993.06K	1.34M	1.41M
Total Debt	n/a	n/a	n/a	n/a	n/a
Common Stock	14.23K	14.23K	14.23K	14.23K	n/a
Retained Earnings	17.17M	18.4M	14.8M	14.07M	12.55M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	17.19M	18.42M	14.82M	14.09M	12.55M
Total Investments	n/a	n/a	n/a	n/a	1.57M